Literature DB >> 20685979

Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain.

Wen-Kwei Chen1, Ingrid Y Liu, Ya-Ting Chang, Yong-Cyuan Chen, Chih-Cheng Chen, Chen-Tung Yen, Hee-Sup Shin, Chien-Chang Chen.   

Abstract

Treatments for chronic musculoskeletal pain, such as lower back pain, fibromyalgia, and myofascial pain syndrome, remain inadequate because of our poor understanding of the mechanisms that underlie these conditions. Although T-type Ca2+ channels (T-channels) have been implicated in peripheral and central pain sensory pathways, their role in chronic musculoskeletal pain is still unclear. Here, we show that acid-induced chronic mechanical hyperalgesia develops in Ca(v)3.1-deficient and wild-type but not in Ca(v)3.2-deficient male and female mice. We also show that T-channels are required for the initiation, but not maintenance, of acid-induced chronic muscle pain. Blocking T-channels using ethosuximide prevented chronic mechanical hyperalgesia in wild-type mice when administered intraperitoneally or intracerebroventricularly, but not intramuscularly or intrathecally. Furthermore, we found an acid-induced, Ca(v)3.2 T-channel-dependent activation of ERK (extracellular signal-regulated kinase) in the anterior nucleus of paraventricular thalamus (PVA), and prevention of the ERK activation abolished the chronic mechanical hyperalgesia. Our findings suggest that Ca(v)3.2 T-channel-dependent activation of ERK in PVA is required for the development of acid-induced chronic mechanical hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685979      PMCID: PMC6634662          DOI: 10.1523/JNEUROSCI.1041-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

Review 1.  Calcium channel functions in pain processing.

Authors:  John Park; Z David Luo
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

Review 2.  T-type voltage-gated calcium channels as targets for the development of novel pain therapies.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  Anatomical and physiological factors contributing to chronic muscle pain.

Authors:  Nicholas S Gregory; Kathleen A Sluka
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 4.  Cav3 T-type channels: regulators for gating, membrane expression, and cation selectivity.

Authors:  A Senatore; W Guan; J D Spafford
Journal:  Pflugers Arch       Date:  2014-02-11       Impact factor: 3.657

5.  ERK, synaptic plasticity and acid-induced muscle pain.

Authors:  Ming-Yuan Min; Hsiu-Wen Yang; Chen-Tung Yen; Chien-Chang Chen; Chih-Cheng Chen; Sin-Jhong Cheng
Journal:  Commun Integr Biol       Date:  2011-07-01

6.  Chronic non-inflammatory muscle pain: central and peripheral mediators.

Authors:  Joseph Lesnak; Kathleen A Sluka
Journal:  Curr Opin Physiol       Date:  2019-06-18

7.  Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Authors:  Shin-Shiou Lin; Bing-Hsiean Tzeng; Kuan-Rong Lee; Richard J H Smith; Kevin P Campbell; Chien-Chang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  A Neural Circuit from Thalamic Paraventricular Nucleus to Central Amygdala for the Facilitation of Neuropathic Pain.

Authors:  Shao-Hua Liang; Wen-Jun Zhao; Jun-Bin Yin; Ying-Biao Chen; Jia-Ni Li; Ban Feng; Ya-Cheng Lu; Jian Wang; Yu-Lin Dong; Yun-Qing Li
Journal:  J Neurosci       Date:  2020-09-21       Impact factor: 6.167

9.  Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.

Authors:  Hong Qu Shan; James A Hammarback; Dwayne W Godwin
Journal:  Alcohol Clin Exp Res       Date:  2013-03-12       Impact factor: 3.455

10.  AKAP-dependent sensitization of Ca(v) 3.2 channels via the EP(4) receptor/cAMP pathway mediates PGE(2) -induced mechanical hyperalgesia.

Authors:  Fumiko Sekiguchi; Yuka Aoki; Maiko Nakagawa; Daiki Kanaoka; Yuta Nishimoto; Maho Tsubota-Matsunami; Rumi Yamanaka; Shigeru Yoshida; Atsufumi Kawabata
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.